Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Dermalax Implant Plus
- Development stage
- Unknown
- Lead developer
- ACROSS Group
- Modality
- Small Molecules
- Administration
- Subcutaneous, Intradermal
01
Overview
Dermalax Implant Plus is a monophasic, cross-linked hyaluronic acid (HA) dermal filler containing lidocaine to minimize discomfort during injection. It is the most viscous formulation in the Dermalax product line, specifically designed for deep subcutaneous or supraperiosteal injection to correct deep wrinkles, such as nasolabial folds, and for facial contouring of the nose, chin, and cheeks. The product utilizes high-purity hyaluronic acid that is cross-linked to enhance stability and longevity within the tissue. By providing physical volume and structural support, it restores facial contours and smooths deep skin depressions. It was developed by Hugel (specifically through its subsidiary Across) and has been evaluated in clinical trials for non-inferiority against established fillers like Restylane Sub-Q.
- Brand names
- Dermalax Implant Plus
- Other names
- Dermalax Implant +
02
Targets
SCN1A (Voltage-gated sodium channel protein type 1 subunit alpha)
Beyond the preview
Go deeper on Dermalax Implant Plus.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Dermalax Implant Plus.